STRS Ohio’s Tenaya Therapeutics TNYA Stock Holding History

STRS Ohio’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,200	Closed	-$37K	–	2288
2022 Q1	$37K	Hold	3,200	–	–	﹤0.01%	1983
2021 Q4	$60K	Hold	3,200	–	–	﹤0.01%	1976
2021 Q3	$66K	Buy	+3,200	New	+$68.8K	﹤0.01%	2021

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

STRS Ohio's TNYA Position: Q2 2022 in Review

STRS Ohio sold out of Tenaya Therapeutics (TNYA) in Q2 2022, closing a stake of 3,200 shares — an estimated $37K sold.

STRS Ohio first reported a position in TNYA in Q3 2021 and held it in 3 quarters. The position peaked at $66K in Q3 2021. 50 funds tracked by Wall St. Rank hold TNYA as of Q2 2022.

STRS Ohio reported no remaining Tenaya Therapeutics position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 3,200 Tenaya Therapeutics shares in Q2 2022, an estimated $37K.
STRS Ohio first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 3 quarters.
STRS Ohio's Tenaya Therapeutics position peaked at $66K in Q3 2021.
50 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.